Filing Flows

Filing Flows › 8-K events › Inspire Medical Systems

Inspire Medical Systems: results of operations

Form 8-K filed Nov 2, 2026 · items 2.02, 7.01

FDA decisionsInspire Medical Systems, Inc. Announces Third Quarter 2026

What the filing says

• Third quarter diluted EPS of $(0.84); adjusted diluted EPS of $0.14 • Third quarter operating cash flow of $46.4 million

ScaleThe filing names $46.4M: about 6% of Inspire Medical Systems' annual revenue ($826.8M, four times the latest quarter).

Read the filing on SEC EDGAR →

What usually followsAcross 69,115 8-Ks reporting Item 2.02 (results of operations) in our universe, the stock's median move the next session was +0.2% (typical size ±3.6%, up 51% of the time); over the following 21 sessions, +1.2%. Every item ranked →

Inspire Medical Systems at a glance

Latest quarterQ3 2026
Revenue$206.7M
Revenue Y/Y-8%
Operating margin-13.9%
IndustrySurgical & Medical Instruments & Apparatus

Inspire Medical Systems, Q3 2026: revenue $207M (-8% year over year), operating margin -13.9%. The chart follows the revenue to costs, profit and cash.

Inspire Medical Systems: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent fda decisions

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.